Ocular Therapeutix, Inc.OCULNASDAQ
LOADING
|||
EV to Sales: Discounted Valuation
Trending higher, below historical average, structural decline.
Left:
||||
Enterprise value to sales ratio
Latest
16.25
↓ 66% below average
Average (9y)
47.22
Historical baseline
Range
High:115.59
Low:3.46
CAGR
-19.6%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 16.25 | +289.8% |
| 2023 | 4.17 | +20.6% |
| 2022 | 3.46 | -64.8% |
| 2021 | 9.82 | -84.3% |
| 2020 | 62.52 | +43.8% |
| 2019 | 43.47 | -29.3% |
| 2018 | 61.52 | +13.0% |
| 2017 | 54.46 | -46.0% |
| 2016 | 100.91 | -12.7% |
| 2015 | 115.59 | - |